Pan-Cancer Metabolic Landscapes: A Multiomics View.
6 affiliations
- 1Department of Orthopedics, Beijing Anzhen Nanchong Hospital, Capital Medical University (Nanchong Central Hospital), Nanchong637000, China.
- 2Department of Orthopedics, Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong637000, China.
- 3Department of Oncology, Beijing Anzhen Nanchong Hospital, Capital Medical University (Nanchong Central Hospital), Nanchong637000, China.
- 4Department of Oncology, Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong637000, China.
- 5National Bioinformatics Infrastructure Sweden (NBIS), Science for Life Laboratory, Lund University, Lund22387, Sweden.
- 6Department of Immunotechnology, Lund University, Medicon Village, Lund22387, Sweden.
Abstract
Metabolic reprogramming fuels cancer progression, but whether common metabolic patterns exist across diverse malignancies remains incompletely understood. To address this, we integrated large-scale proteomic, transcriptomic [The Cancer Genome Atlas (TCGA)], and spatial transcriptomic (Spatial Meta-Transcriptome Database) data sets comprising 3226 samples across 24 human cancer types. Utilizing a highly controlled, predominantly patient-matched design to minimize background noise, we characterized the pan-cancer metabolic landscape via reaction-level functional task scoring, pathway enrichment, multiomics integration, network modeling, survival analysis, and microenvironmental coupling. Consistently upregulated glycan biosynthesis pathways─particularly fucosylation and sialylation─and broadly enhanced nucleotide metabolism highlighted conserved programs potentially associated with tumor growth, adaptation, and immune evasion. These signatures proved robust against variations in tumor purity across the TCGA cohorts. Furthermore, gene coexpression network modeling prioritized specific hub genes associated with this pan-cancer restructuring. Exploratory high-resolution mapping aligned tumor immunogenicity with specific glycan pathways. Notably, tumor-intrinsic glycan upregulation negatively correlates with their immune score alignment, suggesting that tumor hyperactivation may obscure immune signals in bulk tissue. Together, our results define a robust computational landscape of shared metabolic alterations, providing a data-driven framework to guide future experimental validation of candidate therapeutic targets across diverse oncological contexts.
Related
- Metabolic transcriptomic subtyping defines distinct immunogenomic and clinical landscapes in non–small cell lung cancer
- Multiomics, multi-species profiling, and animal validation identify mitoxyperilysis as a conserved therapeutic target in metabolic dysfunction-associated steatohepatitis.
- Hypothesis-Generating Single-Cell Analysis of the Endometrial Cancer Immune Microenvironment With Complementary Multiomics Evidence.
- Evaluating Large Language Models as Tools to Navigate Researchers in Rapidly Evolving Research Landscapes: A Case Study in Cancer Drug Response Prediction
- Distinct genomic landscapes of mismatch-repair deficiency (dMMR)/microsatellite instability-high (MSI-H) gastrointestinal (GI) cancer depending on tumor mutation burden (TMB) levels.
BibTeX
@article{bai2026pancancer,
title = {{Pan-Cancer Metabolic Landscapes: A Multiomics View.}},
author = {Yiguang Bai and Qiaoling Chen and Yuan Li},
journal = {Journal of proteome research},
year = {2026},
month = oct,
doi = {10.1021/acs.jproteome.6c00346},
url = {https://europepmc.org/article/MED/42918100},
note = {CC BY},
}
RIS
TY - JOUR
TI - Pan-Cancer Metabolic Landscapes: A Multiomics View.
AU - Yiguang Bai
AU - Qiaoling Chen
AU - Yuan Li
PY - 2026
DA - 2026/10/01
JO - Journal of proteome research
DO - 10.1021/acs.jproteome.6c00346
UR - https://europepmc.org/article/MED/42918100
AB - Metabolic reprogramming fuels cancer progression, but whether common metabolic patterns exist across diverse malignancies remains incompletely understood. To address this, we integrated large-scale proteomic, transcriptomic [The Cancer Genome Atlas (TCGA)], and spatial transcriptomic (Spatial Meta-Transcriptome Database) data sets comprising 3226 samples across 24 human cancer types. Utilizing a highly controlled, predominantly patient-matched design to minimize background noise, we characterized the pan-cancer metabolic landscape via reaction-level functional task scoring, pathway enrichment, multiomics integration, network modeling, survival analysis, and microenvironmental coupling. Consistently upregulated glycan biosynthesis pathways─particularly fucosylation and sialylation─and broadly enhanced nucleotide metabolism highlighted conserved programs potentially associated with tumor growth, adaptation, and immune evasion. These signatures proved robust against variations in tumor purity across the TCGA cohorts. Furthermore, gene coexpression network modeling prioritized specific hub genes associated with this pan-cancer restructuring. Exploratory high-resolution mapping aligned tumor immunogenicity with specific glycan pathways. Notably, tumor-intrinsic glycan upregulation negatively correlates with their immune score alignment, suggesting that tumor hyperactivation may obscure immune signals in bulk tissue. Together, our results define a robust computational landscape of shared metabolic alterations, providing a data-driven framework to guide future experimental validation of candidate therapeutic targets across diverse oncological contexts.
SN - 1535-3893
SN - 1535-3907
ER -